Epigenetic modulation with oral histone deacetylase (HDAC) inhibitor as a new treatment option in JIA

by Damjanov N, Furlan A, Vojinovic J, D’Urzo C, Dinarello CA
Published 2011-09-01

LI-RADS: a conceptual and historical review from its beginning to its recent integration into AASLD clinical practice guidance

by Elsayes KM, Kielar AZ, Chernyak V, Morshid A, Furlan A, Masch WR, Marks RM, Kamaya A, Do RKG, Kono Y, Fowler KJ, Tang A, Bashir MR, Hecht EM, Jambhekar K, Lyshchik A, Rodgers SK, Heiken JP, Kohli M, Fetzer DT, Wilson SR, Kassam Z, Mendiratta-Lala M, Singal AG, Lim CS, Cruite I, Lee J, Ash R, Mitchell DG, McInnes MDF, Sirlin CB
Published 2019-02-01